List of Excipients in API rivastigmine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rivastigmine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | EXELON | rivastigmine | 0078-0501 | .ALPHA.-TOCOPHEROL | |
| Sandoz Inc | RIVASTIGMINE | rivastigmine | 0781-7304 | .ALPHA.-TOCOPHEROL | |
| Rebel Distributors Corp | EXELON | rivastigmine | 21695-357 | ALPHA-TOCOPHEROL | |
| Physicians Total Care Inc | EXELON | rivastigmine | 54868-6070 | ALPHA-TOCOPHEROL | |
| Physicians Total Care Inc | EXELON | rivastigmine tartrate | 54868-4512 | CELLULOSE, MICROCRYSTALLINE | |
| Physicians Total Care Inc | EXELON | rivastigmine tartrate | 54868-4512 | FERRIC OXIDE RED | |
| Physicians Total Care Inc | EXELON | rivastigmine tartrate | 54868-4512 | FERRIC OXIDE YELLOW | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing rivastigmine
Detailed excipient profiles for rivastigmine
Excipient focus: .ALPHA.-TOCOPHEROL
rivastigmine drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
| Sandoz Inc | rivastigmine | 0781-7304 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: ALCOHOL
rivastigmine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
| American Health Packaging | rivastigmine tartrate | 68084-550 |
| Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing ALCOHOL
Excipient focus: ALPHA-TOCOPHEROL
rivastigmine drug variants containing ALPHA-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | rivastigmine | 21695-357 |
| Physicians Total Care Inc | rivastigmine | 54868-6070 |
| Amneal Pharmaceuticals LLC | rivastigmine | 65162-825 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing ALPHA-TOCOPHEROL
Excipient focus: AMMONIA
rivastigmine drug variants containing AMMONIA
rivastigmine drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
rivastigmine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
| American Health Packaging | rivastigmine tartrate | 68084-550 |
| Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
rivastigmine drug variants containing CELLULOSE, MICROCRYSTALLINE
rivastigmine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE K25-31
rivastigmine drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing COPOVIDONE K25-31
Excipient focus: D&C BLACK NO. 2
rivastigmine drug variants containing D&C BLACK NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing D&C BLACK NO. 2
Excipient focus: D&C RED NO. 28
rivastigmine drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
| American Health Packaging | rivastigmine tartrate | 68084-550 |
| Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
rivastigmine drug variants containing D&C YELLOW NO. 10
rivastigmine drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIMETHICONE
rivastigmine drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | rivastigmine | 65162-825 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing DIMETHICONE
Excipient focus: DIMETHICONE 12500
rivastigmine drug variants containing DIMETHICONE 12500
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing DIMETHICONE 12500
Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
rivastigmine drug variants containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Excipient focus: DOCUSATE SODIUM
rivastigmine drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing DOCUSATE SODIUM
Excipient focus: FD&C BLUE NO. 1
rivastigmine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
rivastigmine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
rivastigmine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rivastigmine tartrate | 54868-6145 |
| McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
rivastigmine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rivastigmine tartrate | 54868-6145 |
| Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
| American Health Packaging | rivastigmine tartrate | 68084-550 |
| Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
rivastigmine drug variants containing FERRIC OXIDE RED
rivastigmine drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
rivastigmine drug variants containing FERRIC OXIDE YELLOW
rivastigmine drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
rivastigmine drug variants containing FERROSOFERRIC OXIDE
rivastigmine drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
rivastigmine drug variants containing GELATIN
rivastigmine drug variants not containing GELATIN
Excipient focus: HYPROMELLOSE
rivastigmine drug variants containing HYPROMELLOSE
rivastigmine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
rivastigmine drug variants containing HYPROMELLOSE 2910
rivastigmine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
rivastigmine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
| Macleods Pharmaceuticals Limited | rivastigmine tartrate | 33342-089 |
| Cadila Pharmaceuticals Limited | rivastigmine tartrate | 71209-012 |
| Modavar Pharmaceuticals LLC | rivastigmine tartrate | 72241-011 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
rivastigmine drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: LIGHT MINERAL OIL
rivastigmine drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | rivastigmine | 16714-115 |
| Zydus Lifesciences Limited | rivastigmine | 51956-0001 |
| Zydus Pharmaceuticals USA Inc | rivastigmine | 70710-1196 |
| Alvogen Inc | rivastigmine transdermal system | 47781-304 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing LIGHT MINERAL OIL
Excipient focus: MAGNESIUM STEARATE
rivastigmine drug variants containing MAGNESIUM STEARATE
rivastigmine drug variants not containing MAGNESIUM STEARATE
Excipient focus: POLYISOBUTYLENE
rivastigmine drug variants containing POLYISOBUTYLENE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | rivastigmine | 16714-115 |
| Alvogen Inc | rivastigmine transdermal system | 47781-304 |
| Zydus Lifesciences Limited | rivastigmine | 51956-0001 |
| Zydus Pharmaceuticals USA Inc | rivastigmine | 70710-1196 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing POLYISOBUTYLENE
Excipient focus: POLYTETRAFLUOROETHYLENE
rivastigmine drug variants containing POLYTETRAFLUOROETHYLENE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing POLYTETRAFLUOROETHYLENE
Excipient focus: POTASSIUM HYDROXIDE
rivastigmine drug variants containing POTASSIUM HYDROXIDE
rivastigmine drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
rivastigmine drug variants containing PROPYLENE GLYCOL
rivastigmine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
rivastigmine drug variants containing SHELLAC
rivastigmine drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
rivastigmine drug variants containing SILICON DIOXIDE
rivastigmine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
rivastigmine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
| Macleods Pharmaceuticals Limited | rivastigmine tartrate | 33342-089 |
| Aurobindo Pharma Limited | rivastigmine tartrate | 65862-648 |
| REMEDYREPACK INC | rivastigmine tartrate | 70518-3012 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TITANIUM DIOXIDE
rivastigmine drug variants containing TITANIUM DIOXIDE
rivastigmine drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
rivastigmine drug variants containing TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
| Amneal Pharmaceuticals LLC | rivastigmine | 65162-825 |
| >Company | >Ingredient | >NDC |
rivastigmine drug variants not containing TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
